The Pioneer in Integrated Skincare Solutions Brings Advanced Anti-Aging Solutions to New Heights with Technology Inspired by the Effects of Neurotoxin Injections NEW YORK , July 23, 2024 /PRNewswire/ -- SkinCeuticals, the #1 Medical Skincare Brand, announces the brand's biggest launch to-date: P-TIOX, a new clinically backed peptide serum designed to reduce the appearance of contraction lines and reveal glass skin radiance. This innovative serum offers advanced wrinkle modulation, improved skin smoothness, and radiant skin. Inspired by the effects of neurotoxin injections and the new microtox trend, P-TIOX features a patent-pending blend of advanced peptides amplified by synergistic actives to reduce the appearance of nine types of contraction lines and reveal visibly smooth, radiant skin on all skin types and tones.
P-TIOX is physician-tested to complement neurotoxin injections and is effective on its own to achieve needle-free wrinkle correction without the aid of professional injectables. Additionally, P-TIOX is formulated with a novel blend of advanced peptides amplified by potent actives. This patent-pending combination of ingredients has shown powerful synergy compared to a peptide-based formula alone 1 : Advanced Peptide Complex with 2% Acetyl Hexapeptide-8 + 2% Dipeptide Diaminobutyroyl inspired by the effects of neurotoxin injections to help reduce the appearance of contraction lines.
Glass Skin Complex with 5% Polyhydroxy Acid + 5% Niacinamide + 1% Laminaria Extract.